Skip to main content

ScholarsBetaWeill Cornell Medicine

Browse About Sign in

Loading search results…

Scholars @ Weill Cornell Medicine

Help & supportPhase 1 prototype

Loading search results…

Browse

Scholars8,803 Publications201,348 Funding7,268 Clinical research2

FiltersClear all

Status

Recruiting1
Enrolling by invitation1

Study type

Interventional2

Phase

Phase 41
Not applicable1

Investigator

Michael G Kaplitt1
Parag Goyal1

Department

Medicine1
Neurological Surgery1

Condition

Alzheimer Disease2
Atrial Fibrillation19
Heart Failure15
Stroke8
Cardiovascular Diseases7

Intervention type

Device2
Drug7
Behavioral2
Other2
Biological1

Sponsor type

Industry1
WCM (investigator-initiated)1

Start date

to

Alzheimer Disease×Device×Clear all

Showing 1–2 of 2 studiesSort:

RecruitingInterventional · Not applicableNCT03671889 ↗
Assessment of Safety and Efficacy of ExAblate Blood-Brain Barrier Disruption for the Treatment of Patients With Probable Alzheimer's Disease

Show all 50

Show fewer

Michael G KaplittPI

Intervention: Device: Blood Brain Barrier (BBB) Disruption
Dates: Sep 2018 – Jan 2028 (est.)
Sponsor: InSightec

Alzheimer Disease

Enrolling by invitationInterventional · Phase 4NCT07252310 ↗

Pilot Study of Acceptability and Feasibility of StudyU for N-of-1 Trials

Intervention: Drug: beta blockers · Device: StudyU Application
Dates: Feb 2026 – Feb 2027 (est.)
Sponsor: Weill Medical College of Cornell University

HFrEF - Heart Failure With Reduced Ejection FractionHeart FailureHeart Failure, Systolic+1 more